WOBURN, Mass.--(BUSINESS WIRE)--Jan. 18, 2006--Aphios Corporation today announced the formation of a limited liability subsidiary Amyxa Pharmaceuticals, which will focus on the discovery and development of novel anti-influenza drugs from marine microorganisms and terrestrial plants that are active and protective against different strains of Influenza A including H5N1 viruses and Influenza B.
